New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
BeiGene Ltd.
www.beigene.com
Latest From BeiGene Ltd.
AstraZeneca And Galapagos Shine At The 15th Annual Scrip Awards
The pharma, biotech and allied industries came together in London on 4 December to celebrate another year of achievement at the 15th Annual Scrip Awards, hosted by the broadcaster Fiona Bruce.
Who's In And Who's Out In China's Largest Reimbursed Drug List Revamp?
Some manufacturers willing to offer global-low prices in exchange for reimbursement coverage in the world's second-largest pharma market.
Hello NMPA: China Approval For Astellas's Xtandi, Keytruda Set For Fourth Indication
Astellas’s Xtandi gets its latest approval in China, where Merck’s Keytruda is set for another win.
Keeping Track Of Approvals: Two Novel Drugs (Givlaari And Xcopri), A Project Orbis Collaboration (Calquence) And Another Humira Biosimilar
The latest news on US FDA drug approvals.
Company Information
- Industry
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Large Molecule
- Antibodies
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- In Vitro Diagnostics
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Alias(es)
- BeiGene (Beijing) Co. Ltd.
- Ownership
- Public
- Headquarters
-
Worldwide
-
Asia
-
China
-
China
-
Asia
- Parent & Subsidiaries
- BeiGene Ltd.
- Senior Management
-
John V Oyler, CEO
Howard Liang, PhD, CFO & Chief Strategy Officer - Contact Info
-
BeiGene Ltd.
Phone: 10 58958000
No. 30 Science Park Rd. Zhong-Guan-Cun
Life Science Pk
Changping District, 102206
China
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BeiGene Ltd.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice